Michel Gaston Joseph Grandgeorge

Title: Michel Gaston Joseph Grandgeorge: Innovator in Recombinant Albumin Purification

Introduction

Michel Gaston Joseph Grandgeorge is a notable inventor based in Lyons, France. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of recombinant proteins. His innovative work has led to advancements that benefit both the industry and patients.

Latest Patents

Grandgeorge holds a patent for a process aimed at the purification of recombinant albumin. This process is designed to produce a highly pure recombinant albumin solution with a nickel ion content of less than 100 ng per gram of albumin. The method involves a series of chromatography, concentration, and diafiltration steps, ensuring the quality and safety of the final product. He has 1 patent to his name.

Career Highlights

Currently, Grandgeorge is associated with Novozymes Biopharma Dk A/S, a company known for its focus on biopharmaceutical solutions. His role at the company allows him to apply his expertise in recombinant protein purification, contributing to the development of high-quality therapeutic products.

Collaborations

Throughout his career, Grandgeorge has collaborated with esteemed colleagues, including Hendrik Van Urk and David John Mead. These partnerships have fostered an environment of innovation and shared knowledge, enhancing the impact of their work in the biopharmaceutical sector.

Conclusion

Michel Gaston Joseph Grandgeorge is a distinguished inventor whose work in the purification of recombinant albumin has made a significant impact in the biopharmaceutical industry. His contributions continue to advance the field and improve therapeutic solutions for patients.